The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was
published on 11 January 2020, triggering intense global R&D activity to develop a vaccine …

Profile of vaccine developers. Of the confirmed active vaccine candidates, 56 (72%) are
being developed by private/industry developers, with the remaining 22 (28%) of projects …

The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …

The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
affected billions of lives globally, and the world hopes to end this epidemic by effective …

In the absence of specific treatment or an effective vaccine, the SARS-CoV epidemic was
brought to an end through public health tools like isolation, quarantine, physical distancing …

There is an unprecedented need to manufacture and distribute enough safe and effective
vaccine to immunize an extraordinarily large number of individuals in order to protect the …

ABSTRACT Introduction The coronavirus 19 (COVID-19) pandemic triggered a
simultaneous global demand for preventative vaccines, which quickly became a high priority …

A novel coronavirus SARS-CoV-2 causing Coronavirus disease 2019 (COVID-19) has
entered the human population and has spread rapidly around the world in the first half of …

COVID-19 emerged in late 2019 and has rapidly spread through many countries globally.
The causative SARS-CoV-2 virus was not known until recently, and there is little or no …

The world remains cautiously optimistic about a COVID-19 vaccine that is relatively safe and
efficacious and that offers sufficient long-lasting protection/immunity by neutralizing the virus …